http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108508055-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N24-088 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08 |
| filingDate | 2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108508055-B |
| titleOfInvention | Metabonomics-based diabetes resistance potential marker metabolic pathway of Guangxi Yaoshan sweet tea and research method |
| abstract | The invention discloses a metabolic pathway of antidiabetic potential markers of Guangxi Yaoshan sweet tea based on metabonomics and a research method, and relates to a research method of action mechanisms of natural botanical drugs. The invention aims to solve the problem that the existing single pharmacological method cannot systematically and comprehensively evaluate the action mechanism of natural plant medicines. The method is realized by the following steps: (1) detecting and analyzing urine metabolites of streptozotocin induced diabetic rats and Yaoshan sweet dried tea prognosis by adopting a nuclear magnetic resonance technology; (2) screening and identifying 9 Yaoshan sweet tea antidiabetic related urine potential markers; (3) 6 anti-diabetic metabolic pathways of Yaoshan sweet tea are screened and analyzed. The invention can comprehensively, efficiently and quickly evaluate the antidiabetic action mechanism of Yaoshan sweet tea from the whole level without bias, and provides a basis for the clarification and further development of the action mechanism of national medicines. |
| priorityDate | 2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.